Invention Grant
- Patent Title: Bradykinin B2 receptor antagonists
-
Application No.: US17033347Application Date: 2020-09-25
-
Publication No.: US11261173B2Publication Date: 2022-03-01
- Inventor: Christoph Gibson , Joern Saupe , Horst-Dieter Ambrosi , Lars Ole Haustedt
- Applicant: Pharvaris Netherlands B.V.
- Applicant Address: NL Leiden
- Assignee: Pharvaris Netherlands B.V.
- Current Assignee: Pharvaris Netherlands B.V.
- Current Assignee Address: NL Leiden
- Agency: Wilson Sonsini Goodrich & Rosati
- Priority: EP17203675 20171124
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D401/04 ; C07D405/14 ; C07D413/14 ; C07D417/14
Abstract:
The invention relates to a compound according to general formula (I), which acts as a bradykinin (BK) B2 receptor antagonist; to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament.
Public/Granted literature
- US20210017158A1 NOVEL BRADYKININ B2 RECEPTOR ANTAGONISTS Public/Granted day:2021-01-21
Information query
